Suppr超能文献

印度南部女性自我采集阴道样本用于 HPV DNA 检测的诊断准确性。

Diagnostic accuracy of self-collected vaginal samples for HPV DNA detection in women from South India.

机构信息

Gynecologic Oncology Division, Department of Obstetrics and Gynecology, Government Medical College, Kozhikode, Kerala, India.

Manipal Institute of Virology, Manipal Academy of Higher Education, Manipal, Karnataka, India.

出版信息

Int J Gynaecol Obstet. 2020 May;149(2):219-224. doi: 10.1002/ijgo.13116. Epub 2020 Mar 1.

Abstract

OBJECTIVES

To assess the efficacy of self-collected vaginal samples compared with physician-collected cervical samples for the detection of HPVDNA.

METHODS

A hospital-based cross-sectional study was carried out among patients with newly diagnosed cervical cancer attending the Gynecologic Oncology Division, Department of Obstetrics and Gynecology and Radiation Oncology Department at Government Medical College, Kozhikode, Kerala between March 2017 and April 2019. Consenting patients collected their vaginal samples, followed by cervical sample collection by the clinician. The paired samples were transported at 4-8 °C to the laboratory. Amplification of LCR/E6/E7 regions of the HPV genome was done by polymerase chain reaction (PCR). The agreement level between paired samples was assessed by the Kappa index.

RESULTS

Among the 114 cervical cancer patients enrolled in the present cross-sectional study, the prevalence of HPV DNA was 78.1% (95% confidence interval [CI] 69.2%-85%) in cervical samples and 77.2% in vaginal samples (95% CI 68.7%-83.9%). The overall agreement between the two sampling methods was 93.9% and the kappa value was 0.82 (P<0.001). The sensitivity of HPV detection using vaginal samples was 98.9% (95% CI 93.9%-99.8%) and the specificity was 100% (95% CI 86.7%-100%) with cervical sampling as the gold standard. By Kappa index, an almost perfect agreement for HPV DNA detection between self-collected and physician-collected samples was observed.

CONCLUSION

Self-collection of vaginal samples ensures equity of cervical cancer screening in low-income countries such as India.

摘要

目的

评估自我采集阴道样本与医生采集宫颈样本检测 HPVDNA 的效果。

方法

本研究为 2017 年 3 月至 2019 年 4 月在喀拉拉邦科泽科德政府医学院妇产科妇科肿瘤学系和放射肿瘤学系就诊的新诊断宫颈癌患者进行了一项基于医院的横断面研究。同意的患者采集了阴道样本,然后由临床医生采集宫颈样本。将配对样本在 4-8°C 下运送到实验室。通过聚合酶链反应(PCR)扩增 HPV 基因组的 LCR/E6/E7 区域。通过 Kappa 指数评估配对样本之间的一致性水平。

结果

在本横断面研究中,纳入了 114 名宫颈癌患者,宫颈样本 HPV DNA 阳性率为 78.1%(95%可信区间[CI] 69.2%-85%),阴道样本 HPV DNA 阳性率为 77.2%(95%CI 68.7%-83.9%)。两种采样方法的总体一致性为 93.9%,Kappa 值为 0.82(P<0.001)。使用阴道样本检测 HPV 的敏感性为 98.9%(95%CI 93.9%-99.8%),特异性为 100%(95%CI 86.7%-100%),以宫颈采样为金标准。根据 Kappa 指数,自我采集和医生采集样本检测 HPV DNA 的一致性几乎为完美。

结论

自我采集阴道样本可确保在印度等低收入国家公平地进行宫颈癌筛查。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验